ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancer R Taftaf, X Liu, S Singh, Y Jia, NK Dashzeveg, AD Hoffmann, ... Nature communications 12 (1), 4867, 2021 | 170 | 2021 |
Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2 L El-Shennawy, AD Hoffmann, NK Dashzeveg, KM McAndrews, PJ Mehl, ... Nature communications 13 (1), 405, 2022 | 154 | 2022 |
Cell death decision by p53 via control of the mitochondrial membrane N Dashzeveg, K Yoshida Cancer letters 367 (2), 108-112, 2015 | 111 | 2015 |
EGFR inhibition blocks cancer stem cell clustering and lung metastasis of triple negative breast cancer X Liu, V Adorno-Cruz, YF Chang, Y Jia, M Kawaguchi, NK Dashzeveg, ... Theranostics 11 (13), 6632, 2021 | 61 | 2021 |
Palmdelphin, a novel target of p53 with Ser46 phosphorylation, controls cell death in response to DNA damage N Dashzeveg, N Taira, ZG Lu, J Kimura, K Yoshida Cell death & disease 5 (5), e1221-e1221, 2014 | 60 | 2014 |
ITGA2 promotes expression of ACLY and CCND1 in enhancing breast cancer stemness and metastasis V Adorno-Cruz, AD Hoffmann, X Liu, NK Dashzeveg, R Taftaf, B Wray, ... Genes & diseases 8 (4), 493-508, 2021 | 58 | 2021 |
Tumor suppressor p53 induces miR‐1915 processing to inhibit Bcl‐2 in the apoptotic response to DNA damage K Nakazawa, N Dashzeveg, K Yoshida The FEBS journal 281 (13), 2937-2944, 2014 | 55 | 2014 |
Extracellular Domains I and II of cell-surface glycoprotein CD44 mediate its trans-homophilic dimerization and tumor cluster aggregation M Kawaguchi, N Dashzeveg, Y Cao, Y Jia, X Liu, Y Shen, H Liu Journal of Biological Chemistry 295 (9), 2640-2649, 2020 | 34 | 2020 |
Programmed cell death 6, a novel p53‐responsive gene, targets to the nucleus in the apoptotic response to DNA damage K Suzuki, N Dashzeveg, ZG Lu, N Taira, Y Miki, K Yoshida Cancer science 103 (10), 1788-1794, 2012 | 33 | 2012 |
New advances and challenges of targeting cancer stem cells NK Dashzeveg, R Taftaf, EK Ramos, L Torre-Healy, A Chumakova, ... Cancer research 77 (19), 5222-5227, 2017 | 31 | 2017 |
Crosstalk between tumor suppressors p53 and PKCδ: Execution of the intrinsic apoptotic pathways N Dashzeveg, K Yoshida Cancer Letters 377 (2), 158-163, 2016 | 25 | 2016 |
Dynamic glycoprotein hyposialylation promotes chemotherapy evasion and metastatic seeding of quiescent circulating tumor cell clusters in breast cancer NK Dashzeveg, Y Jia, Y Zhang, L Gerratana, P Patel, A Shajahan, ... Cancer discovery 13 (9), 2050-2071, 2023 | 21 | 2023 |
Circulating ACE2-expressing exosomes block SARS-CoV-2 infection as an innate antiviral mechanism L El-Shennawy, AD Hoffmann, NK Dashzeveg, PJ Mehl, Z Yu, VL Tokars, ... BioRxiv, 2020.12. 03.407031, 2020 | 21 | 2020 |
Machine learning-assisted elucidation of CD81–CD44 interactions in promoting cancer stemness and extracellular vesicle integrity EK Ramos, CF Tsai, Y Jia, Y Cao, M Manu, R Taftaf, AD Hoffmann, ... Elife 11, e82669, 2022 | 20 | 2022 |
Unique molecular signatures sustained in circulating monocytes and regulatory T cells in convalescent COVID-19 patients AD Hoffmann, SE Weinberg, S Swaminathan, S Chaudhuri, ... Clinical Immunology 252, 109634, 2023 | 17 | 2023 |
Transcriptional induction of protein kinase C delta by p53 tumor suppressor in the apoptotic response to DNA damage N Dashzeveg, S Yogosawa, K Yoshida Cancer Letters 374 (1), 167-174, 2016 | 13 | 2016 |
Extracellular vesicle-based diagnostics and engineered exosomes for targeted therapeutics against cancer H Liu, EK Ramos, NK Dashzeveg, G Kibria US Patent 10,874,610, 2020 | 7 | 2020 |
Computational ranking-assisted identification of Plexin-B2 in homotypic and heterotypic clustering of circulating tumor cells in breast cancer metastasis E Schuster, N Dashzeveg, Y Jia, K Golam, T Zhang, A Hoffman, Y Zhang, ... bioRxiv, 2023.04. 10.536233, 2023 | 3 | 2023 |
Physics-driven structural docking and protein language models accelerate antibody screening and design for broad-spectrum antiviral therapy. HF Almubarak, W Tan, AD Hoffmann, J Wei, L El-Shennawy, JR Squires, ... Biorxiv: the Preprint Server for Biology, 2024 | 1 | 2024 |
METHODS AND COMPOSITIONS FOR THE TREATMENT OF CORONAVIRUS INFECTION, INCLUDING SARS-COV-2 H Liu, LKMA El-shennawy, AD Hoffman, D Fang, EJ Schuster, ... US Patent App. 18/658,779, 2024 | | 2024 |